CVS Health Co. (NYSE:CVS) Shares Acquired by Apollon Wealth Management LLC

Apollon Wealth Management LLC boosted its position in CVS Health Co. (NYSE:CVS) by 78.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 49,316 shares of the pharmacy operator’s stock after buying an additional 21,750 shares during the period. Apollon Wealth Management LLC’s holdings in CVS Health were worth $3,894,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Bryn Mawr Capital Management LLC lifted its stake in shares of CVS Health by 74.0% in the 3rd quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator’s stock valued at $3,017,000 after purchasing an additional 18,385 shares during the period. Value Partners Investments Inc. raised its holdings in CVS Health by 26.5% in the 3rd quarter. Value Partners Investments Inc. now owns 991,601 shares of the pharmacy operator’s stock worth $69,261,000 after purchasing an additional 207,702 shares during the period. Sonora Investment Management Group LLC boosted its position in CVS Health by 1.6% during the third quarter. Sonora Investment Management Group LLC now owns 50,488 shares of the pharmacy operator’s stock worth $3,525,000 after purchasing an additional 774 shares in the last quarter. Checchi Capital Advisers LLC raised its stake in shares of CVS Health by 2.3% during the 3rd quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock worth $726,000 after buying an additional 233 shares during the period. Finally, Personal CFO Solutions LLC increased its holdings in CVS Health by 2.6% in the 3rd quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock worth $1,351,000 after acquiring an additional 491 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of a number of research reports. Wells Fargo & Company cut their target price on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research note on Monday, April 8th. Barclays lowered their price target on CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday. UBS Group lowered CVS Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $85.00 to $60.00 in a report on Thursday. The Goldman Sachs Group reduced their target price on shares of CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research report on Thursday. Finally, Mizuho dropped their price objective on shares of CVS Health from $86.00 to $72.00 and set a “buy” rating for the company in a research note on Thursday. Eight research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $80.35.

Insider Activity at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The sale was disclosed in a filing with the SEC, which is available at this link. In other CVS Health news, Director Edward J. Ludwig purchased 1,000 shares of the stock in a transaction dated Thursday, May 2nd. The shares were acquired at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the transaction, the director now directly owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the sale, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The disclosure for this sale can be found here. Company insiders own 0.24% of the company’s stock.

CVS Health Stock Performance

CVS traded up $0.07 during trading on Monday, hitting $55.97. 16,502,619 shares of the stock were exchanged, compared to its average volume of 11,808,347. The firm has a market capitalization of $70.26 billion, a P/E ratio of 9.84, a PEG ratio of 0.88 and a beta of 0.56. CVS Health Co. has a 1-year low of $53.70 and a 1-year high of $83.25. The stock has a fifty day moving average price of $72.36 and a two-hundred day moving average price of $73.18. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.38). The company had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The business’s revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the firm earned $2.20 EPS. As a group, sell-side analysts predict that CVS Health Co. will post 7.03 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.75%. The ex-dividend date of this dividend was Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.